BTL Secures Patent Victory Over WonderFace Device

BTL Group, renowned for its medical technologies, has successfully concluded multiple patent infringement cases against Lexter Microelectronic Engineering Systems S.L., the producer of the WonderFace device. The disputes, occurring across various jurisdictions, revolved around the unauthorized use of BTL's EMFACE® technology, which integrates radiofrequency and electrical muscle stimulation for facial treatments.

Following the settlement, Lexter agreed to halt the manufacturing, marketing, and distribution of WonderFace globally. Tomas Schwarz, BTL's CEO, emphasized the global importance of this settlement, highlighting their commitment to safeguarding intellectual property and customer investments.

BTL's extensive patent collection underscores its status as an innovator in medical technology, offering solutions in numerous medical fields. For further insights on EMFACE®, explore www.emface.com.